China NMPA Drug Inspection - Chengdu Lier Pharmaceutical Co., Ltd. - alum
China NMPA drug inspection for Chengdu Lier Pharmaceutical Co., Ltd. published July 20, 2017. Drug: alum. The State Administration for Market Regulation (now NMPA) issued Announcement No. 113 of 2017 on July 20, 2017, concerni
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Chengdu Lier Pharmaceutical Co., Ltd. published July 20, 2017. Drug: alum. The State Administration for Market Regulation (now NMPA) issued Announcement No. 113 of 2017 on July 20, 2017, concerni
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox